Please login to the form below

Not currently logged in
Email:
Password:

iBio and GE Healthcare extend Alliance into plant-based vaccines

Will use technology to make plants produce proteins

iBio and GE Healthcare have entered an alliance to commercialise plant-based technologies for the manufacture of biopharmaceuticals and vaccines, extending a collaboration originally formed in 2010.

The latest agreement involves the creation of a single facility with the ability to reduce the capital and operating costs of biotherapeutic and vaccine manufacture.

It combines GE Healthcare's technologies to manufacture biopharmaceuticals and other protein-based therapeutics, with iBio's own platform iBioLaunch.

This tool causes plants to rapidly produce high quantities of proteins that can then be used in vaccines.

It is based on gene expression technology, which can be scaled-up within low cost, controlled-growth facilities, according to iBio.

This provides potential to manufacture proteins that cannot be commercially produced in any other system.

The agreement will also see iBio's R&D collaborator, Fraunhofer US Center for Molecular Biotechnology (CMB) continue its involvement in the iBioLaunch platform.

Previous work involving the plant-technology includes an alliance between iBio and the Bill & Melinda Gates Foundation that has been used to produce an avian influenza vaccine candidate that successfully completed phase I clinical trials recently.

27th July 2012

Share

Related Hub content

    Your search did not contain any words. Please try again.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PAN Unlimited

PAN Unlimited specialises in developing Influential Creativity - ideas that make people feel, behave and think differently (www.influentialcreativity.com) Influential Creativity...

Latest intelligence

Free White Paper: Customer Experience for Pharma
To learn why an effective customer experience strategy is vital for pharma, download our white paper “Customer experience for pharma” to learn more....
How ethical is your brand plan? Introducing the hEQ.
Assess your brand plan’s Healthcare Ethics Quotient and see how these questions can give your brand plan a new perspective and engage your internal teams and external customers....
solution_options.png
Why e-detailing must give options to healthcare professionals
We know, we know. You want to talk about your treatment right away, but this really is an essential step that will make your e-detailing even more credible....